StockIQpro
NYSE:CVM

Cel Sci Corp.

Track all markets on TradingView
Track all markets on TradingView

Cel Sci Corp. reported net income of −$25.4M in fiscal 2025. Free cash flow was −$17.2M, and the diluted share count rose 125.1%.Summary generated from Cel Sci Corp.'s SEC filings. Latest annual report filed Dec 29, 2025.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−176.3%
Debt / equity0.50
Free cash flow−$17.2M
FCF marginn/a
Share count change+125.1%

Financials

Fiscal years, $M
Item20212022202320242025
Revenuen/an/an/an/an/a
Operating income−36−36−31−26−25
Net income−36−37−32−27−25
Free cash flow−28−19−23−19−17

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)